PALO ALTO, Calif., March 27, 2017 /PRNewswire/ -- Varian Medical Systems (NYSE: VAR) announced today that its management will hold a mid-year review on May 10, 2017 in Freedom Hall at the New York Stock Exchange, 2 Broad St., New York, NY 10005, beginning at 11:30 am ET. The lunch meeting is scheduled to end at 1:30 p.m.
Presentations will cover the company's financial performance for the first half of fiscal year 2017 as well as the company's strategy for its software and hardware products. Management will include Dow Wilson, President and CEO; Elisha Finney, Senior Vice President and CFO; Kolleen Kennedy, Executive Vice President and President of Oncology Systems; Dee Khuntia, Senior Vice President and Chief Medical Officer; Corey Zankowski, Senior Vice President and Chief Technical Innovation Officer; and Spencer Sias, Vice President of Corporate Communications and Investor Relations.
To attend, please RSVP to Katie Glenn at Katie.email@example.com or by calling 650-424-5631. To gain access to the stock exchange, participants must be listed in advance on the Varian guest list and be prepared to present a government issued photo identification at the door.
The event also will be webcast and may be accessed via: https://event.webcasts.com/starthere.jsp?ei=1141558
Web conferences will be archived on the company website for a year. Additional information about Varian Medical Systems can be obtained on the company's website. Investors can subscribe to receive automatic "e-mail alerts" regarding Varian news and events via the company website at www.varian.com/en-au/investor.
About Varian Medical Systems
Varian Medical Systems focuses energy on saving lives and is the world's leading manufacturer of medical devices and software for treating and managing cancer. Headquartered in Palo Alto, California, Varian employs approximately 6,400 people at sites around the world. For more information, visit http://www.varian.com and follow @VarianMedSys on Twitter.
FOR INFORMATION CONTACT:
Spencer Sias, (650) 424-5782
Vice President, Corporate Communications
and Investor Relations
SOURCE Varian Medical Systems